Value of genetic testing in the prevention of coronary heart disease events-Reference-Cited by-同舟云学术

Value of genetic testing in the prevention of coronary heart disease events

Published:2019-01-15 Issue:1 Volume:14 Page:e0210010
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hynninen Yrjänä^ORCID,Linna Miika,Vilkkumaa Eeva

Funder

Tekes

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference42 articles.

1. Cardiovascular diseases (CVDs),2016

2. Global Action Plan for the Prevention and Control of Noncommunicable Diseases: 2013–2020,2013

3. Cardiovascular disease risk profiles;KM Anderson;Am Heart J,1991

4. Prediction of coronary heart disease using risk factor categories;PWF Wilson;Circulation,1998

5. Sydäninfarkti- ja aivohalvausriskin arviointi FINRISKI-tutkimuksessa (The FINRISK FUNCTION: Estimation of the risk of coronary events and stroke in the Finnish population);E Vartiainen;Suom Lääkäril,2007

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic‐Guided Pharmacotherapy for Coronary Artery Disease: A Systematic and Critical Review of Economic Evaluations;Journal of the American Heart Association;2024-03-05

2. Polygenic Risk Scores;Clinical Lipidology;2024

3. The risk of venous thromboembolism in oral contraceptive users: the role of genetic factors—a prospective cohort study of 240,000 women in the UK Biobank;American Journal of Obstetrics and Gynecology;2023-09

4. Health Economic Research Assessing the Value of Early Detection of Cardiovascular Disease: A Systematic Review;PharmacoEconomics;2023-06-16

5. Decoding the Interplay of Genes and MicroRNAs in Cardiovascular Disease;Human Genetics and Genomics;2023-05-01